Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Incannex Healthcare (IXHL) Income from Continuing Operations (2023 - 2025)

Incannex Healthcare's Income from Continuing Operations history spans 3 years, with the latest figure at 6521000.0 for Q4 2025.

  • For Q4 2025, Income from Continuing Operations fell 10.66% year-over-year to 6521000.0; the TTM value through Dec 2025 reached 48500000.0, down 104.0%, while the annual FY2025 figure was 46885000.0, 154.0% down from the prior year.
  • Income from Continuing Operations for Q4 2025 was 6521000.0 at Incannex Healthcare, down from 6407000.0 in the prior quarter.
  • Across five years, Income from Continuing Operations topped out at 726000.0 in Q3 2023 and bottomed at 31604000.0 in Q2 2025.
  • The 3-year median for Income from Continuing Operations is 5962000.0 (2024), against an average of 7824200.0.
  • The largest annual shift saw Income from Continuing Operations tumbled 646.56% in 2024 before it soared 34.21% in 2025.
  • A 3-year view of Income from Continuing Operations shows it stood at 5241000.0 in 2023, then fell by 12.44% to 5893000.0 in 2024, then fell by 10.66% to 6521000.0 in 2025.
  • Per Business Quant, the three most recent readings for IXHL's Income from Continuing Operations are 6521000.0 (Q4 2025), 6407000.0 (Q3 2025), and 31604000.0 (Q2 2025).